# Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPC

> **NCT04855331** · NA · UNKNOWN · sponsor: **Fudan University** · enrollment: 120 (estimated)

## Conditions studied

- Borderline Resectable Pancreatic Cancer

## Interventions

- **PROCEDURE:** Laparoscopic pancreatoduodenectomy
- **PROCEDURE:** Open pancreatoduodenectomy

## Key facts

- **NCT ID:** NCT04855331
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-15
- **Primary completion:** 2024-12
- **Final completion:** 2025-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-05-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04855331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04855331, "Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPC". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04855331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*